Melanoma
DNP modified autologous melanoma cell vaccine induced unique T cell-mediated immune response in study
Published in Vaccine Weekly, June 26th, 2002
Avax Technologies, Inc., (AVXT) announced the presentation of data at the 93rd Annual Meeting of the American Association for Cancer Research (AACR) entitled "Sequence analysis of T cell receptors of lymphocytes infiltrating melanoma metastases after administration of autologous, dinitrophenyl (DNP)-modified vaccine." The study, utilizing new analytical techniques on cells collected in previous clinical trials, indicates that Avax's DNP modified autologous melanoma cell vaccine induced a unique immunological response within the patients' tumors.
Avax's DNP modified autologous melanoma cell vaccine is a therapeutic vaccine for metastatic melanoma made from a patient's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2002-06-26)
More Articles from Vaccine Weekly
- Human Papillomavirus Vaccine
Protein fusion augments HPV-E7 immunogenicity - Tuberculosis
Statistical model useful for determining prevalence of TB in people with BCG vaccination - AIDS and HIV Vaccine
Herpes simplex vectors can enhance immunogenecity - Brain Cancer
Vaccine shows promise in early research - Vaccine Safety
Mixing diphtheria-tetanus-acellular pertussis vaccines (DTaP) from different manufacturers is safe and effective - Anthrax
Vaccine meets safety requirements - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
